Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial
Back de Levia-Hidalgo, A, de Leviva-Prez, A (Oct 2019) 'Pancreatic extracts for the treatment of diabetes (18891914): Acomatol', American Journal of Therapeutics , 27, 21-e12
These patches do not contain GLP-1 ingredients, but the name is used as a marketing tactic to associate them with the effectiveness of real GLP-1 medications
It is also worth noting that in obese patients with T2DM, GLP-1RA-mediated weight reduction has been associated with the detection rate of breast cancer [34], with the highest incidence observed in patients who experienced more than 10% weight loss following treatment [35]
Monitor your symptoms closely
and N.H